FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Florian,Kowarsch

第一单位： Computer Vision Lab, Faculty of Informatics, Technical University of Vienna, Vienna, Austria.

作者： Florian,Kowarsch ^[1] ; Margarita,Maurer-Granofszky ^[2] ; Lisa,Weijler ^[3] ; Matthias,Wödlinger ^[1] ; Michael,Reiter ^[1] ; Angela,Schumich ^[2] ; Tamar,Feuerstein ^[1] ; Simona,Sala ^[2] ; Michaela,Nováková ^[2] ; Giovanni,Faggin ^[4] ; Giuseppe,Gaipa ^[5] ; Ondrej,Hrusak ^[6] ; Barbara,Buldini ^[7] ; Michael N,Dworzak ^[5]

作者单位： Computer Vision Lab, Faculty of Informatics, Technical University of Vienna, Vienna, Austria. ^[1] Immunological Diagnostics, St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria. ^[2] Labdia Labordiagnostik GmbH, Vienna, Austria. ^[3] The Rina Zaizov Division of Pediatric Hematology-Oncology, Schneider's Children's Medical Center, Petah Tikva, Israel. ^[4] M. Tettamanti Foundation Research Center, Department of Pediatrics, University of Milano-Bicocca, Monza, Italy. ^[5] Department of Pediatric Haematology and Oncology, University Hospital Motol, Prague, Czech Republic. ^[6] Pediatric Hematology, Oncology and Stem Cell Transplant Division, Maternal and Child Health Department, University of Padova, Padova, Italy. ^[7] Advanced Diagnostics and Target Discovery in ALL, Fondazione istituto di Ricerca pediatrica Città della Speranza, Padova, Italy. ^[8]

关键词 CD48 CD99 T-lineage acute lymphoblastic leukemia feature importance flow cytometry minimal residual disease support vector machine